CEA increases in many tumor tissues such as lung cancer, gastrointestinal neoplasms, breast cancer, carcinoid, and liver cancer and become an independent prognosis factor for NSCLC 8. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.